KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Average (2016 - 2025)

Historic Equity Average for Amgen (AMGN) over the last 16 years, with Q4 2025 value amounting to $9.1 billion.

  • Amgen's Equity Average rose 3635.48% to $9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 billion, marking a year-over-year increase of 3635.48%. This contributed to the annual value of $7.3 billion for FY2025, which is 2003.47% up from last year.
  • Latest data reveals that Amgen reported Equity Average of $9.1 billion as of Q4 2025, which was up 3635.48% from $8.5 billion recorded in Q3 2025.
  • Amgen's Equity Average's 5-year high stood at $9.4 billion during Q1 2021, with a 5-year trough of $1.7 billion in Q2 2022.
  • Moreover, its 5-year median value for Equity Average was $6.7 billion (2024), whereas its average is $6.3 billion.
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 8103.07% in 2022, then surged by 26368.82% in 2023.
  • Over the past 5 years, Amgen's Equity Average (Quarter) stood at $7.5 billion in 2021, then plummeted by 50.97% to $3.7 billion in 2022, then soared by 89.88% to $6.9 billion in 2023, then dropped by 3.49% to $6.7 billion in 2024, then skyrocketed by 36.35% to $9.1 billion in 2025.
  • Its Equity Average was $9.1 billion in Q4 2025, compared to $8.5 billion in Q3 2025 and $6.8 billion in Q2 2025.